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81 Requirement of endosomal SNARE protein complex in CFTR
activity/trafﬁcking regulation
R. Cle´ment1, F. Fresquet1, P. Melin1, F. Becq1, A. Kitzis1, V. Thoreau1. 1CNRS
UMR 6187, IPBC, Universite´ de Poitiers, Poitiers, France
We previously showed, using several cell types, that the endosomal SNARE protein
complex (described to mediate fusion of endosomes) is involved in CFTR regula-
tion. Notably, we evidenced by co-IP experiments that CFTR could interact with
each of the four endosomal SNAREs (syn7, syn8, vti1b and VAMP8). Moreover,
overexpression of any of these proteins (or siRNA-induced vti1b depletion) elicited
a dramatic decrease of CFTR channel activity, as monitored by iodide efﬂux assay.
This was correlated to the loss of plasma membrane localization of CFTR which
was then only found in perinuclear vesicles decorated by Rab11a protein, namely
the recycling endosomes.
To understand how the SNARE proteins are involved in CFTR regulation we are
currently testing in which transport step the correct endosomal SNARE complex
activity is required. Using HeLa cell lines stably expressing WT- or F508del-form
of CFTR, we established that RNA interference of any of the four SNAREs reduces
WT-CFTR activity (this also seems to be the case in 16HBE14o- cells endogenously
expressing WT-CFTR), without affecting the B to C band maturation efﬁciency.
Interestingly SNARE depletions were without effect upon temperature-rescued
F508del-CFTR activity in HeLa cells. Finally, using cell surface biotinylation
experiments, the involvement of SNARE proteins on CFTR plasma membrane
targeting, internalization and recycling is presently tested.
Since F508del-CFTR ER-export can be rescued in several ways without fully cor-
recting post-ER defects, our work will supply new informations on the mechanisms
involved in CFTR regulation after plasma membrane targeting.
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82 Increased interaction of F508del-CFTR with K8/K18 cytokeratin
network by direct binding of K8 to NBD1
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We have previously reported an increased expression of cytokeratins 8/18 (K8/K18)
in cells expressing F508del-CFTR. This is associated with colocalization of CFTR
and K18 in the vicinity of the endoplasmic reticulum, while this is reversed by
curcumin, resulting in the rescue of F508del-CFTR. We aimed to investigate if
the K8/K18 network interacts directly with CFTR and, if conﬁrmed, to precise the
interaction site. Firstly, CFTR was immunoprecipitated from HeLa cells transfected
with either wild-type CFTR, F508del-CFTR, or pTracer alone. Precipitates were
subjected to 2D-electrophoresis and differential spots identiﬁed by MALDI-TOF.
K8 and K18 were signiﬁcantly increased in F508del-CFTR precipitates. In a second
approach, by surface plasmon resonance, we immobilized mouse NBD1, either
normal or bearing F508del, and used K8 and K18 as analytes. K8 strongly interacted
with both NBD1 forms, while K18 binding was limited. The afﬁnity constants of K8
were 42 nM for normal and 27 nM for mutated NBD1. The afﬁnity for human NBD1
was the same as for the mouse molecule. Binding of K8 alone was stronger than in
the presence of K18. In all cases, the interaction was totally inhibited by 10mM ATP.
These results conﬁrm a physical interaction of CFTR with the cytokeratin network
and suggest a major contribution of K8 binding to NBD1. As F508del mutation
primes binding afﬁnity, this interaction may play a role in the defective trafﬁcking
of F508del. This suggests the cytokeratin network as a potential therapeutic target
in CF.
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83 The calpain-caspase 12-caspase 3 cascade leading to apoptosis
is altered in F508del-CFTR expressing cells
M. Kerbiriou1, N. Benz1, P. Trouve´1, C. Fe´rec1. 1INSERM U613, Brest, France
In cystic ﬁbrosis (CF) the most common mutation of the cystic ﬁbrosis transmem-
brane conductance regulator (CFTR) is a missing phenylalanine at position 508
(F508del). The F508del-protein is incorrectly folded and retained in the endoplasmic
reticulum (ER). Eukaryotic cells respond to the accumulation of misfolded proteins
in the ER by activating the unfolded protein response (UPR). We previously showed
that the UPR may be triggered in CF. Since prolonged UPR activation leads to
apoptosis via the calcium (Ca2+)-calpain (Cal-1)-caspase 12 (Csp-12)-caspase 3
(Csp-3) cascade and because apoptosis is altered in CF, our aim was to compare
the ER stress-induced apoptosis pathway between wild type (Wt) and F508del-
CFTR expressing cells. The comparison was also studied after UPR induction
by thapsigargin (Tg). We ﬁrst assessed the cell viability of Wt and CF cells and
observed a decreased cell death of the CF cells. Then we compared the intracytosolic
Ca2+ concentration ([Ca2+]i) between Wt and CF cells by microﬂuorometry and
showed a lower increase of [Ca2+]i in CF cells after Tg treatment. Using western
blot experiment we studied Cal-1, Csp-12 and Csp-3 expression in Wt and CF cells
without Tg treatment and showed a decreased basal expression of these proteins in
CF cells. Moreover we observed a lower and delayed increase of Cal-1 and Csp-12
expression and especially no accumulation of the active form of Csp-3 after Tg
treatment in CF cells. Finally we studied Csp-12 and Csp-3 activities in Wt and
CF cells by ﬂuorometry and showed a decreased and delayed Csp-12 activation
and a Csp-3 activation defect in CF cells. In conclusion we show that the altered
apoptosis observed in CF under stress conditions (inﬂammation, infection) involves
an altered Cal-1, Csp-12 and mostly Csp-3 activation
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84 Pharmacological inhibition of CFTR modiﬁes cyclooxygenase-1
and -2 expression and PGD2 production in Calu-3 cells
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Pharmacological inhibition of CFTR with the speciﬁc inhibitor CFTRinh172 has
been shown to induce a Cystic Fibrosis phenotype with enhanced NFkappaB
activation and IL-8 secretion. Altered prostaglandin production has also been
observed in Cystic Fibrosis, but its origin and characteristics remain unclear. The
present work was undertaken to-determine whether the CFTRinh172 was also able
to alter the pattern of the cyclooxygenase-1 and -2 expression and the production
of PGD2 in Calu-3, the human pulmonary cells with a very high expression of an
active CFTR.
By Western blotting, we found that treating the cells for 48 hours with CFTRinh172
(10 microg/ml)increased by 15 and 30% respectively the amounts of COX-1 and
COX-2 proteins present in the internal membranes of the control cells (conﬂuent
cells maintained without FCS). The CFTRinh172 was no longer active on the COXs
expression when Il-1beta (which increases COX-1 expression by about 20% and
practically doubles that of COX-2) was administered during the 3 last hours of the
incubation. The PGD2 content of the same cells was measured by immunoenzymatic
assay. Inhibiting CFTR during 48 hours decreased their PGD2 content by about
30%. The PGD content of the control cells was also decreased by 35.5% after a
3hour-incubation with IL-1beta, but, on the opposite, was practically doubled in the
cells treated with CFTRinh172.
These preliminary data suggest the existence of a complex relationship between
CFTR activity, cyclooxygenases expression, and PGD2 production.
